|
Program Evaluation Reports (PERs) and Program Evaluation Plans (PEPs)
NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.
At the current time, no PERs or PEPs specific to Texas City Chemicals, Inc. have been developed. However, we have developed PERs and PEPs that pertain to multiple sites. To view all PERs and PEPs that have been developed, please refer to the Program Evaluation Reports (PERs) and Program Evaluation Plans (PEPs) page.
Top of Page
Worker Outreach Activities
Based on a recommendation from the Advisory Board to provide workers and site experts with opportunities to participate in developing the technical documents used in dose reconstruction, NIOSH established a Worker Outreach Program.
At Worker Outreach Meetings, current and former DOE and AWE employees have opportunities to obtain information about Site Profiles, Technical Basis Documents, and Technical Information Bulletins, and to provide information for consideration and possible use in dose reconstruction. This process is valuable to ensure that the technical documents used in dose reconstruction contain correct and useful information.
Below are the Worker Outreach Activities for Texas City Chemicals, Inc.:
- November 15, 2007
Town Hall Meeting on Texas City Chemicals, Inc.
Captain's Room of the Nessler Center
2010 5th Avenue North
Texas City, Texas
7:00 p.m. to 9:00 p.m.
Former workers, as well as family members, are invited and encouraged to attend.
Purpose: This meeting is an opportunity for former workers, and their families, to hear about
NIOSH's responsibilities under Part B of EEOICPA, including its dose reconstruction
program and the SEC petitioning process. Please note this meeting is not an opportunity
to discuss individual claim status; however, representatives from NIOSH and the
Department of Labor will be available to answer general questions related to EEOICPA.
Minutes
 PDF 38 KB (8 pages)
- October 18, 2007
Meeting with former workers
International Union of Operating Engineers Local 564 hall
Texas City, Texas
Final Minutes
2:00 p.m. meeting
PDF 75 KB (23 pages)
7:00 p.m. meeting
PDF 51 KB (14 pages)
Top of Page
Advisory Board Work Group on the Use of Surrogate Data
This Work Group will consider the conditions under which "surrogate" data can be used as a valid substitute for actual data for a given site.
The Work Group will seek to establish the type and importance of various parameters (e.g., type of nuclide, amounts of material, chemical and physical
forms, processes, working conditions, and other such parameters) that impact on worker dose, and will consider the extent to which such parameters at one
site may apply to other sites. The Work Group may also consider the extent to which theoretical considerations can be properly used to bound dosed in the
absence of actual workplace measurements. The Work Group should strive to develop a policy recommendation that can be adopted by the Board regarding the
use of surrogate data. This Work Group was asked to consider the application of surrogate data criteria to the Texas City Chemicals, Inc., site in relation
to the SEC petition for that facility.
- Work Group Members
James Malcolm Melius, M.D., Dr. P.H.-Chair
Josie Beach
James E. Lockey, M.D., M.S.
Wanda I. Munn
- Meeting Information
- November 5, 2010
Teleconference Meeting of the Advisory Board's Work Group on the Use of Surrogate Data
1:00 p.m. (Eastern time)
This meeting is open to the public, but without a public comment period.
Teleconference call access is available for this meeting
and it is limited only by the number of ports available.
To access the meeting via the teleconference call access,
you must dial 1-866-659-0537. To be automatically connected
to the meeting, you will need to enter the following participant
code: 9933701.
Agenda
PDF 9 KB (1 page)
Transcript
PDF 170 KB (62 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
- May 13, 2010
Teleconference Meeting of the Advisory Board's Work Group on the Use of Surrogate Data
1:00 p.m. (Eastern time)
This meeting is open to the public, but without a public comment period.
Teleconference call access is available for this meeting
and it is limited only by the number of ports available.
To access the meeting via the teleconference call access,
you must dial 1-866-659-0537. To be automatically connected
to the meeting, you will need to enter the following participant
code: 9933701.
Agenda
PDF 45 KB (1 page)
Transcript
PDF 131 KB (69 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
- January 11, 2010
Teleconference Meeting of the Advisory Board's Work Group on the Use of Surrogate Data
1:00 p.m. (Eastern time)
This meeting is open to the public, but without a public comment period.
Teleconference call access is available for this meeting
and it is limited only by the number of ports available.
To access the meeting via the teleconference call access,
you must dial 1-866-659-0537. To be automatically connected
to the meeting, you will need to enter the following participant
code: 9933701.
An agenda will be provided at a later date.
Transcript
PDF 198 KB (92 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
- May 8, 2009
Teleconference Meeting of the Advisory Board's Work Group on the Use of Surrogate Data
1:00 p.m. (Eastern time)
This meeting is open to the public, but without a public comment period.
Teleconference call access is available for this meeting
and it is limited only by the number of ports available.
To access the meeting via the teleconference call access,
you must dial 1-866-659-0537. To be automatically connected
to the meeting, you will need to enter the following participant
code: 9933701.
Agenda
PDF 6 KB (1 page)
Transcript
PDF 107 KB (59 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
- June 9, 2008
Teleconference Meeting of the Advisory Board's Work Group on Surrogate Data
11:30 a.m. (Eastern time)
This meeting is open to the public, but without a public comment period.
Teleconference call access is available for this meeting
and it is limited only by the number of ports available.
To access the meeting via the teleconference call access,
you must dial 1-866-659-0537. To be automatically connected
to the meeting, you will need to enter the following participant
code: 9933701.
Agenda items will be provided at a later date.
Transcript
PDF 58 KB (34 pages)
Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.
Top of Page
Comments on Texas City Chemicals, Inc., Documents
How to Submit Comments
Comments on Texas City Chemicals, Inc., documents can be submitted to the NIOSH Docket Officer electronically by e-mail at NIOCINDOCKET@cdc.gov or printed comments can be mailed to NIOSH Docket Office, Robert A. Taft Laboratories, MS-C34, 4676 Columbia Parkway, Cincinnati, OH 45226. Please include the Site Profile/Docket Number (112) on all comments.
Comments Received
- Letter to the Advisory Board from Congressman Pete Olson, regarding Texas City Chemicals SEC petition (NIOSH SEC-00088)
(October 1, 2010)
PDF 72 KB (2 pages)
Letter from the Advisory Board in response to Congressman Pete Olson's October 1, 2010, inquiry regarding the
Texas City Chemicals SEC petition (NIOSH SEC-00088)
(November 3, 2010)
PDF 143 KB (2 pages)
- Comments from Daniel W. McKeel, Jr., M.D., on the Texas City Chemicals, Inc., SEC Petition
(NIOSH SEC-00088)
(July 26, 2010)
PDF 106 KB (3 pages)
- Comments from Daniel W. McKeel, Jr., M.D., on the Texas City Chemicals, Inc., SEC Petition
Evaluation Report (NIOSH SEC-00088)
(June 24, 2010)
PDF 126 KB (2 pages)
- Comments from Daniel W. McKeel, Jr., M.D., on the Texas City Chemicals, Inc., SEC Petition
(NIOSH SEC-00088)
(January 7, 2010)
PDF 34 KB (1 page)
- Draft: A Focused Review of the NIOSH Evaluation Report for the Texas City Chemical Company SEC Petition
Contract No. 200-2004-03805
Task Order No. 5
July 2008
PDF 440 KB (44 pages)
Top of Page
Special Exposure Cohort Petition Information for Texas City Chemicals, Inc.
- Class Added to the SEC
All Atomic Weapons Employer employees who worked at Texas City Chemicals, Inc., from October 5, 1953, through September 30, 1955, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees included in the Special Exposure Cohort.
- Petitions Qualified for Evaluation
Location: Texas City, Texas
Job Titles and/or Job Duties: All employees
Period of Employment: January 1, 1952 through December 31, 1956
- Federal Register Notice Announcing that the Texas City Chemicals, Inc., SEC Petition has met the Minimum Qualifications for Review and Evaluation
August 28, 2007
PDF 73 KB (1 page)
- Copy of the Petition Received
Texas City Chemicals, Inc. Petition
(March 13, 2007)
PDF 551 KB (10 pages)
- SEC Petition Evaluation Report
Texas City Chemicals, Inc. SEC Petition Evaluation Report
(Revised October 19, 2010)
PDF 450 KB (64 pages)
- Petition to be Discussed by the Advisory Board
The Advisory Board discussed the petition on November 17, 2010, April 7, 2008, and June 26, 2008, during its regular meetings.
- Advisory Board Recommendation on SEC Petition
Advisory Board recommendation regarding Texas City Chemicals, Inc. SEC Petition (October 5, 1953, through September 30, 1955)
(December 8, 2010)
PDF 48 KB (2 pages)
- HHS Letters to Congress Regarding the SEC Petition
HHS Letters to Congress regarding the Texas City Chemicals, Inc. SEC petition (October 5, 1953, through September 30, 1955)
(January 6, 2011)
PDF 102 KB (9 pages)
- Federal Register Notice: Designation of a Class of Employees
for Addition to the Special Exposure Cohort
Designation of a Class of Employees from Texas City Chemicals, Inc. to the SEC (October 5, 1953, through September 30, 1955)
(January 21, 2011)
PDF 50 KB (1 page)
- HHS Designation of Additional Members to the SEC
HHS Designation of additional members from Texas City Chemicals, Inc. to the SEC (October 5, 1953, through September 30, 1955)
(January 6, 2011)
PDF 40 KB (4 pages)
- Effective Date for the SEC Class
February 5, 2011
- Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
Final Effect of Designation of a Class of Employees from Texas City Chemicals, Inc. for Addition to the SEC (October 5, 1953, through September 30, 1955)
(February 11, 2011)
PDF 49 KB (1 page)
- Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
Letter to DOL Regarding the Addition of a New Class of Employees from Texas City Chemicals, Inc. to the SEC (October 5, 1953, through September 30, 1955)
(February 7, 2011)
PDF 33 KB (1 page)
Top of Page
Previous Versions of Texas City Chemicals, Inc. Documents
Top of Page
|
Search NIOSH
.gif){kind=spacer}
